Balyasny Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,826
| Closed | -$80.3K | – | 2177 |
|
|
2025
Q1 | $80.3K | Buy |
+3,826
| New | +$80.3K | ﹤0.01% | 1920 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2104 |
|
|
2024
Q2 | – | Sell |
-406
| Closed | -$122K | – | 2104 |
|
|
2024
Q1 | $122K | Buy |
+406
| New | +$122K | ﹤0.01% | 1862 |
|
|
2018
Q2 | – | Sell |
-1,020
| Closed | -$1.66M | – | 1701 |
|
|
2018
Q1 | $1.66M | Buy |
+1,020
| New | +$1.66M | 0.01% | 869 |
|